Maine prescription drug price transparency rules take hold

February 5, 2020 GMT

AUGUSTA, Maine (AP) — Maine’s new prescription drug price transparency rules are now in effect.

The new rules have arrived in the wake of a law designed to make drug pricing less confusing for the state’s consumers. The rules require drug makers, wholesale distributors and pharmacy benefit managers to report prescription price data to the Maine Health Data Organization, the Senate Majority Office of the Maine Legislature said Tuesday.

Democratic Sen. Eloise Vitelli of Arrowsic said the state “can begin to shine a light on what is driving these outrageous prices and take aggressive action to curb the cost of medication once and for all.”


She and other supporters of the new rules said the goal of the new requirements is to get a better understanding of prescription drug pricing so lawmakers can take more steps to lower the costs and work on industry reforms.

The reporting deadline for data is March 31 this year.